Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan and sildenafil in pulmonary hypertension during cardiac anesthesia
PACTR202209903019732Phase 2Recruiting
- Sponsor
- Mansoura University
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sildenafil and bosentan in pulmonary hypertension (PH) (2 arms), sponsored by Mansoura University. Primary endpoints: Systolic pulmonary artery pressure, Pulmonary vascular resistance and 1 more. Started Sep 2022; status: recruiting.
02
Drugs
sildenafilbosentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on PACTR202209903019732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202209903019732.